Full-dose prednisone (FP) regimen in the treatment of high-risk immunoglobulin A
nephropathy (IgAN) patients, is still controversial. The pulsed intravenous …

Introduction IgA nephropathy (IgAN) has a heterogeneous presentation and the progression
to end stage renal disease (ESRD) is often influenced by demographics, ethnicity, as well as …

Background: IgA nephropathy (IgAN) has a high degree of heterogeneity in clinical and
pathological features. Among all subsets of IgAN, the pathogenesis of IgAN with minimal …

Purpose To evaluate the differences in clinicopathological features and outcomes of IgA
nephropathy (IgAN) patients with and without nephrotic syndrome. Methods In this …

Introduction Immunoglobulin A nephropathy (IgAN) presents various clinical manifestations
and pathological phenotypes. Approximately 5% of patients with IgAN present with early …

Mild mesangial proliferative IgA nephropathy with minimal change disease (MCD-IgAN) and
mild mesangial proliferative IgA nephropathy without minimal change disease (Non-MCD …

Background Alternative complement pathway dysregulation plays a key role in
glomerulonephritis (GN) and is associated with C3 deposition. Herein, we examined …

IgA 肾病(IgA nephropathy, IgAN) 是全球最常见的原发性肾小球肾炎并且可进展至终末期肾病,
IgA1 分子沉积在肾小球系膜是其区别于其他原发性肾小球肾炎的明显特征. 近年来, IgAN …

Springer MRW: [AU:, IDX:] Page 1 Electron Microscopy of IgA Nephropathy Verena Brocker
Contents Definition of the Disease ...................................................................................... 1 …

Minimal change disease (MCD) is a glomerular disorder characterized by a lack of
discernible glomerular pathology on light microscopy but abnormal podocyte architecture on …